The U.S. Food and Drug Administration (FDA) has approved the Promega OncoMate MSI Dx Analysis System designed to identify ...
PIMJETMI® (pimicotinib) is a new systemic treatment option for certain U.S. adult patients with symptomatic tenosynovial ...
First lentiviral-vector-based in vivo CAR-T product from China to receive a U.S. FDA IND clearance; a Phase Ib study in R/R B ...
Sanyou Biopharmaceuticals Co., Ltd. ("Sanyou Bio") recently announced the completion of a Series C financing round worth ...
Preliminary Phase 1/1b data presented at SITC 2026 showed responses in five of seven evaluable patients whose cancers had ...
China's National Medical Products Administration (NMPA) has approved ZEISS PT LUNANA, the first in the Phakic Technology (PT) ...
SINTBILO® (tafolecimab injection) monotherapy significantly decreased non-HDL-C, vLDL-C, ApoB, and Lp (a) after 12-week ...
XtalPi will use AI and robotics to design small molecules against undisclosed targets, while Pierre Fabre will lead clinical ...
Bars count qualifying disclosed events per institution; the label beside each bar gives the largest disclosed figure that ...
Roche is advancing its next-generation sequencing (NGS) ambitions in Asia Pacific following the global launch of AXELIOS 1 in ...
Neobe has secured a seed round of US$6.8 million (£5 million) to accelerate the development of engineered bacteria that break down the physical barriers preventing cancer drugs entering into solid ...